An activated survival-promoting UPR, and specifically activation of the IRE-1/XBP-1 arm of the UPR, was observed in B cells from mouse models and humans with chronic lymphocytic leukemia (CLL) (Kriss et al., 2012). Here, XBP1 is linked to B-cell chronic lymphocytic leukemia.